Pittsburgh Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Pittsburgh
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Pittsburgh News
Kindergarten vaccination rates at many Pittsburgh-area schools are below herd immunity
One in three kindergarteners in Allegheny County were in a classroom with vaccination rates below the herd immunity threshold during the 2023-2024 school year.
Pittsburgh-area Planned Parenthood clinics are closing this month due to staffing shortage
Planned Parenthood has confirmed that its Downtown Pittsburgh location will close Jan. 23 and its Greensburg location will close Saturday. The Bridgeville clinic closed its doors in December. It’s ...
Officials may be ‘all in’ on AI, but there are reasons to worry [column]
Pennsylvania is known for many things: pretzels, Crayola, the Amish, chocolate, Kobe Bryant, cheesesteaks, anthracite coal, Taylor Swift ...
Why does the Commerce Department want to gut Pennsylvania’s high-tech economy? | Opinion
The Commerce Department is floating a proposal that would impede the commercialization of university researchers’ most compelling discoveries from ever reaching American patients and consumers.